Cannabis Suisse CORP. (CSUI) — SEC Filings

Overview

Cannabis Suisse CORP. (CSUI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Oct 10, 2025: CANNABIS SUISSE CORP. (CSUI) reported a net income of $13,907 for the three months ended August 31, 2025, a significant improvement from a net loss of $535,086 in the same period last year. This turnaround was primarily driven by a substantial amortization of debt premium totaling $114,739, coupled

Sentiment Summary

Across 12 filings, the sentiment breakdown is: 3 bearish, 9 neutral. The dominant filing sentiment for Cannabis Suisse CORP. is neutral.

Filing Type Overview

Cannabis Suisse CORP. (CSUI) has filed 6 10-Q, 2 10-K/A, 2 10-K, 2 8-K with the SEC between Jan 2024 to Oct 2025.

Filings by Year

2025 · 2024

Recent Filings (12)

• CANNABIS SUISSE Swings to Profit Amidst Zero Revenue, Going Concern Doubts — 10-Q · Oct 10, 2025 Risk: high
  CANNABIS SUISSE CORP. (CSUI) reported a net income of $13,907 for the three months ended August 31, 2025, a significant improvement from a net loss of $535,086
• Cannabis Suisse Amends 10-K, Auditor Flags Going Concern Risk — 10-K/A · Sep 15, 2025 Risk: high
  CANNABIS SUISSE CORP. (CSUI) filed a 10-K/A on September 15, 2025, solely to correct an inadvertent omission of the date from the Report of Independent Register
• Cannabis Suisse Narrows Loss Amidst 'Going Concern' Warning — 10-K · Sep 12, 2025 Risk: high
  CANNABIS SUISSE CORP. (CSUI) reported a net loss of $456,142 for the fiscal year ended May 31, 2025, a significant improvement from the $1,186,613 net loss in t
• Cannabis Suisse Corp. Files Q3 2025 10-Q — 10-Q · Apr 17, 2025 Risk: low
  Cannabis Suisse Corp. filed its 10-Q for the period ending February 28, 2025. The company, formerly known as Geant Corp. and incorporated in Nevada, operates in
• Cannabis Suisse Corp. Files 10-Q — 10-Q · Jan 13, 2025 Risk: low
  Cannabis Suisse Corp. filed a 10-Q for the period ending November 30, 2024. The company, formerly known as Geant Corp., is incorporated in Nevada and operates i
• Cannabis Suisse Corp. Files Q1 2025 10-Q — 10-Q · Oct 15, 2024 Risk: medium
  Cannabis Suisse Corp. filed a 10-Q for the period ending August 31, 2024. The company, formerly known as Geant Corp., is incorporated in Nevada and operates in
• Cannabis Suisse Corp. Files 10-K Amendment — 10-K/A · Oct 2, 2024 Risk: low
  Cannabis Suisse Corp. filed an amendment to its 10-K for the fiscal year ending May 31, 2024. The company, formerly known as Geant Corp. until July 19, 2016, is
• Cannabis Suisse Corp. Files 2024 10-K — 10-K · Sep 13, 2024 Risk: low
  Cannabis Suisse Corp. filed its 10-K for the fiscal year ending May 31, 2024, reporting its financial performance and business operations. The company, formerly
• Cannabis Suisse Corp. Reports Unregistered Equity Sales — 8-K · May 9, 2024 Risk: medium
  On May 7, 2024, Cannabis Suisse Corp. filed an 8-K report detailing unregistered sales of equity securities. The company, formerly known as Geant Corp. until Ju
• CANNABIS SUISSE CORP. Files Form 10-Q for Period Ending 2024-02-29 — 10-Q · Apr 12, 2024 Risk: low
  CANNABIS SUISSE CORP. (CSUI) filed a Quarterly Report (10-Q) with the SEC on April 12, 2024. CANNABIS SUISSE CORP. filed a Form 10-Q for the period ending Febru
• Cannabis Suisse Corp. Changes Certifying Accountant — 8-K · Mar 18, 2024 Risk: medium
  Cannabis Suisse Corp. filed an 8-K on March 18, 2024, reporting a change in its certifying accountant as of March 14, 2024. The company, formerly known as Geant
• CANNABIS SUISSE CORP. Files Form 10-Q for Period Ending 2023-11-30 — 10-Q · Jan 12, 2024 Risk: low
  CANNABIS SUISSE CORP. (CSUI) filed a Quarterly Report (10-Q) with the SEC on January 12, 2024. CANNABIS SUISSE CORP. filed a Form 10-Q for the period ending Nov

Risk Profile

Risk Assessment: Of CSUI's 12 recent filings, 3 were flagged as high-risk, 3 as medium-risk, and 6 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Cannabis Suisse CORP.'s most recent 10-Q filing (Oct 10, 2025):

• Revenue: $0
• Net Income: $13,907
• EPS: N/A
• Debt-to-Equity: N/A
• Cash Position: $305
• Operating Margin: N/A
• Total Assets: $570,344
• Total Debt: $2,358,409

Key Executives

• Scott McAlister
• CEO

Industry Context

The cannabis industry continues to navigate a complex regulatory landscape, with evolving state-by-state legalization and federal uncertainty impacting market access and operational costs. Companies face intense competition, pressure on pricing, and challenges in securing traditional financing due to the industry's legal status.

Top Tags

10-Q (5) · Going Concern (3) · cannabis (3) · Related Party Transactions (2) · Penny Stock (2) · quarterly-report (2) · financials (2) · CANNABIS SUISSE CORP. (2) · Financial Report (2) · SEC Filing (2)

Key Numbers

• Net Income: $13,907 — Swung from a $535,086 net loss in Q3 2024 to a net income in Q3 2025, primarily due to non-operating factors.
• Rental Income: $0 — Represents a complete cessation of revenue from $7,500 in the prior year, indicating a critical business model failure.
• Accumulated Deficit: $3,043,139 — Highlights significant historical losses and contributes to the 'going concern' doubt.
• Cash at End of Period: $305 — A very low cash balance, down from $2,850, further exacerbating liquidity concerns.
• Common Shares Outstanding: 70,680,938 — Consistent share count, but diluted shares are significantly higher at 203,498,313 due to convertible notes.
• Total Operating Expenses: $84,535 — Increased from $74,983 in the prior year, despite zero revenue, contributing to operational losses.
• Amortization of Debt Premium: $114,739 — A key non-cash item that significantly contributed to the reported net income.
• Loss on Settlement of Debt (2024): $551,677 — Absence of this one-time loss in 2025 was a major factor in the swing to net income.
• Advances From Related Parties: $28,400 — Increased from $19,400, indicating continued reliance on insider funding to sustain operations.
• Convertible Note Payable - Related Party: $1,996,788 — A substantial long-term liability, indicating significant debt owed to related parties.
• Aggregate market value of non-affiliate common stock: $7.86M — As of November 30, 2024, indicating market valuation for public float.
• Common stock shares outstanding: 70.68M — As of September 12, 2025, representing the total shares in circulation.
• Net Loss: $456,142 — for fiscal year ended May 31, 2025, a decrease from $1,186,613 in 2024
• Total Revenue: $22,500 — for fiscal year ended May 31, 2025, down from $30,000 in 2024
• Cash: $2,850 — as of May 31, 2025, indicating severe liquidity issues

Frequently Asked Questions